Development and validation of a 'tablet pole' for the administration of praziquantel in sub-Saharan Africa

被引：58

作者：

Montresor, A

Engels, D

Chitsulo, L

Bundy, DAP

Brooker, S

Savioli, L

机构：

[1] WHO, Dis Control Prevent & Eradicat Parasit Dis & Vect, CH-1211 Geneva 27, Switzerland

[2] World Bank, Human Dev Network, Washington, DC 20433 USA

[3] Univ London Imperial Coll Sci Technol & Med, Sch Med, Partnership Child Dev, Dept Infect Dis Epidemiol, London, England

[4] WHO, Communicable Dis, CDS, Geneva, Switzerland

来源：

TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE | 2001年 / 95卷 / 05期

基金：

英国惠康基金;

关键词：

schistosomiasis; chemotherapy; praziquantel; dosage determination; school survey; population survey; sub-Saharan Africa;

D O I：

10.1016/S0035-9203(01)90034-3

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

A pole estimating, for each individual, the number of praziquantel tablets needed for treatment according to height was tested in 20 data sets (n = 25 688). In more than 98% of the cases the indicated dose was within the range that has proven efficacious and safe (30 and 60 mg/kg).

引用

页码：542 / 544

页数：3

共 6 条

[1] HIGH-DOSE PRAZIQUANTEL FOR NEUROCYSTICERCOSIS - EFFICACY AND TOLERABILITY [J].